Pcn124 - Direct Cost of Allogeneic Hematopoietic Stem Cell Transplantation (Ahsct) for Relapsed/Refractory (Rr) Diffuse Large B-Cell Lymphoma Patients From the French Hospital Perspective

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.207
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcn126 - Direct Cost Study of Allogeneic Hematopoietic Stem Cell Transplantation (Ahsct) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients From the French Hospital Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Allogeneic Hematopoietic Cell Transplantation Impacts on Immune Evasive Mechanisms in Relapsed/Refractory Diffuse Large B-Cell Lymphoma - A Single Center Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Non-Myeloablative Allogeneic Haematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: A Multicentre Experience

British Journal of Haematology
Hematology
2008English

CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Immunotherapy
OncologyAllergyImmunology
2017English

Allogeneic Hematopoietic Stem Cell Transplantation for Primary Mediastinal Large B-Cell Lymphoma Patients Relapsing After High Dose Chemotherapy With Autologous Stem Cell Transplantation: Data From the Japan Society for Hematopoietic Cell Transplantation

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Diffuse Large B-Cell Lymphoma of Bones in a Patient After Allogeneic Hematopoietic Stem Cells Transplantation Due to Hodgkin’s Lymphoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2014English

Pcn177 - Cost-Effectiveness of Tisagenlecleucel for Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma : A Canadian Societal Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Annals of Hematology
MedicineHematology
2013English

Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma

Current Oncology
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy